{
    "organizations": [],
    "uuid": "7aa4d05ea9e1713e9b66c93bea86cd00423940b6",
    "author": "",
    "url": "https://www.reuters.com/article/brief-wave-life-sciences-and-deep-genomi/brief-wave-life-sciences-and-deep-genomics-form-collaboration-to-discover-therapies-for-genetic-neuromuscular-disorders-idUSFWN1RN0MA",
    "ord_in_thread": 0,
    "title": "BRIEF-Wave Life Sciences And Deep Genomics Form Collaboration To Discover Therapies For Genetic Neuromuscular Disorders",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 10, 2018 / 12:47 PM / Updated 12 minutes ago BRIEF-Wave Life Sciences And Deep Genomics Form Collaboration To Discover Therapies For Genetic Neuromuscular Disorders Reuters Staff 1 Min Read \nApril 10 (Reuters) - WAVE Life Sciences Ltd: \n* WAVE LIFE SCIENCES AND DEEP GENOMICS FORM COLLABORATION TO DISCOVER NOVEL THERAPIES FOR GENETIC NEUROMUSCULAR DISORDERS \n* WAVEâ€™S NEXT DMD PROGRAM, TARGETING EXON 53, IS EXPECTED TO INITIATE CLINICAL TRIALS IN Q1 2019 Source text for Eikon: Further company coverage:",
    "published": "2018-04-10T15:44:00.000+03:00",
    "crawled": "2018-04-10T16:05:45.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "life",
        "science",
        "deep",
        "genomics",
        "form",
        "collaboration",
        "discover",
        "therapy",
        "genetic",
        "neuromuscular",
        "disorder",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "wave",
        "life",
        "science",
        "ltd",
        "wave",
        "life",
        "science",
        "deep",
        "genomics",
        "form",
        "collaboration",
        "discover",
        "novel",
        "therapy",
        "genetic",
        "neuromuscular",
        "disorder",
        "wave",
        "next",
        "dmd",
        "program",
        "targeting",
        "exon",
        "expected",
        "initiate",
        "clinical",
        "trial",
        "q1",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}